Medsi.ai Snags $3M in Seed Funding to Pioneer Health 3.0 with Smartphone-Powered Diagnostics

Medsi.ai is excited to announce a groundbreaking milestone as we secure $3,000,000 in new funding, a pivotal step in our journey to redefine digital healthcare. As the first company in the Western Hemisphere to earn Class II SaMD approval, Medsi.ai has pioneered technology that transforms any smartphone into a sophisticated diagnostic tool with medical-grade accuracy. Our innovative platform leverages a 70-second "video selfie" to capture over 6,300 data points and measure more than 30 vital signs and biomarkers, ranging from blood pressure to hemoglobin levels, completely eliminating the need for additional diagnostic hardware. This funding will accelerate our mission of healthcare democratization by enhancing our AI-driven algorithms, expanding our capabilities and refining our real-time monitoring system, ultimately shifting the focus from reactive intervention to proactive, continuous prevention. The investment is earmarked for scaling our health platform to serve a broader spectrum of users—healthcare providers, employers, public health agencies, and individuals alike—ensuring that more people have access to early detection and personalized health insights right from devices they already own. With these financial resources, we are set to fortify our leadership in Health 3.0 by reducing treatment costs by as much as 95% through early interventions and by seamlessly integrating our technology into preventive care models. This announcement marks not just a financial milestone, but a reaffirmation of our commitment to making high-quality healthcare accessible, efficient, and transformational for millions around the world.